Ana D Thomas
Examiner (ID: 7472, Phone: (571)272-8549 , Office: P/3661 )
Most Active Art Unit | 3661 |
Art Unit(s) | 3661 |
Total Applications | 381 |
Issued Applications | 298 |
Pending Applications | 39 |
Abandoned Applications | 44 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18484842
[patent_doc_number] => 20230212150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LPA RECEPTOR ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/062363
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062363
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062363 | LPA receptor antagonists and uses thereof | Dec 5, 2022 | Issued |
Array
(
[id] => 18636147
[patent_doc_number] => 11760731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators
[patent_app_type] => utility
[patent_app_number] => 18/061745
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 16526
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061745 | Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators | Dec 4, 2022 | Issued |
Array
(
[id] => 18285403
[patent_doc_number] => 20230100875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/992399
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992399 | Heterocyclic compounds as immunomodulators | Nov 21, 2022 | Issued |
Array
(
[id] => 18286959
[patent_doc_number] => 20230102431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOSITION FOR ORGANIC LIGHT EMITTING DIODE ENCAPSULATION AND ORGANIC LIGHT EMITTING DIODE DISPLAY MANUFACTURED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 18/056208
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056208
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056208 | COMPOSITION FOR ORGANIC LIGHT EMITTING DIODE ENCAPSULATION AND ORGANIC LIGHT EMITTING DIODE DISPLAY MANUFACTURED THEREFROM | Nov 15, 2022 | Pending |
Array
(
[id] => 18333791
[patent_doc_number] => 20230125739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/984069
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 562
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984069 | PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS | Nov 8, 2022 | Pending |
Array
(
[id] => 18192695
[patent_doc_number] => 20230046214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => PROCESS FOR PREPARATION OF SULFENTRAZONE WITH TANK-MIX COMPATIBILITY
[patent_app_type] => utility
[patent_app_number] => 17/979869
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979869 | Process for preparation of sulfentrazone with tank-mix compatibility | Nov 2, 2022 | Issued |
Array
(
[id] => 18468695
[patent_doc_number] => 20230202977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => CYCLIC LIPIDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/972399
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972399 | Cyclic lipids and methods of use thereof | Oct 23, 2022 | Issued |
Array
(
[id] => 18801295
[patent_doc_number] => 11834446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
[patent_app_type] => utility
[patent_app_number] => 17/969331
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46500
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969331 | Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell | Oct 18, 2022 | Issued |
Array
(
[id] => 18351704
[patent_doc_number] => 20230139815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => CRYSTALLINE FORMS OF A CANNABINOID RECEPTOR TYPE 1 (CB1) MODULATOR AND METHODS OF USE AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/045435
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045435 | Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof | Oct 9, 2022 | Issued |
Array
(
[id] => 18279604
[patent_doc_number] => 20230095076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PREPARATION METHOD OF Cu-Pd-CeO2/GAMMA-Al2O3@NP CATALYST AND SYNTHESIS METHOD OF BENZOPYRAZINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/955012
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/955012 | PREPARATION METHOD OF Cu-Pd-CeO2/GAMMA-Al2O3@NP CATALYST AND SYNTHESIS METHOD OF BENZOPYRAZINE COMPOUNDS | Sep 27, 2022 | Pending |
Array
(
[id] => 18581542
[patent_doc_number] => 20230263794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/953412
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17953412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/953412 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Sep 26, 2022 | Pending |
Array
(
[id] => 18226887
[patent_doc_number] => 20230065881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/934629
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934629 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | Sep 22, 2022 | Pending |
Array
(
[id] => 18948095
[patent_doc_number] => 11891376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Aryl cyclopropyl-amino-isoquinolinyl amide compounds
[patent_app_type] => utility
[patent_app_number] => 17/895436
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8086
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895436 | Aryl cyclopropyl-amino-isoquinolinyl amide compounds | Aug 24, 2022 | Issued |
Array
(
[id] => 18628078
[patent_doc_number] => 20230286902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => LIPID NANOPARTICLE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/821738
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821738 | LIPID NANOPARTICLE COMPOSITION | Aug 22, 2022 | Pending |
Array
(
[id] => 19090915
[patent_doc_number] => 11952345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Method for preparing bipyridine
[patent_app_type] => utility
[patent_app_number] => 17/892212
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4001
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892212 | Method for preparing bipyridine | Aug 21, 2022 | Issued |
Array
(
[id] => 18453235
[patent_doc_number] => 20230194515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => BROAD SPECTRUM KINASE BINDING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/819784
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819784 | BROAD SPECTRUM KINASE BINDING AGENTS | Aug 14, 2022 | Pending |
Array
(
[id] => 18122885
[patent_doc_number] => 20230008495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => NOVEL COMPOUNDS AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2
[patent_app_type] => utility
[patent_app_number] => 17/852595
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852595 | NOVEL COMPOUNDS AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2 | Jun 28, 2022 | Pending |
Array
(
[id] => 18207392
[patent_doc_number] => 20230053649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TEAD INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/808868
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808868 | TEAD INHIBITORS AND USES THEREOF | Jun 23, 2022 | Pending |
Array
(
[id] => 18764012
[patent_doc_number] => 11814398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Macrocyclic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/808418
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 45
[patent_no_of_words] => 41233
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808418 | Macrocyclic compounds and uses thereof | Jun 22, 2022 | Issued |
Array
(
[id] => 18319297
[patent_doc_number] => 20230117425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => IMMUNOMODULATOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/838400
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838400 | Immunomodulator compounds | Jun 12, 2022 | Issued |